Dr. Reddy's, Hospira Want Full Fed. Circ. To Redo Lilly IP Win
A Federal Circuit panel misapplied an exception to prosecution history estoppel when deciding that Dr. Reddy's and Hospira infringed a patent covering Eli Lilly's cancer drug Alimta, the generic-drug makers have...To view the full article, register now.
Already a subscriber? Click here to view full article